He argues speed is the wrong first question, saying the drugs don't do the work on their own. A short take with no new data.
Recap by typeshit. Post by @josh.holyfield on Instagram.
The surgeon says that after a 45 lb loss on a GLP-1, getting enough daily protein with a low appetite becomes the harder part.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
The writer cites a Gallup survey putting about 11 percent of Americans on GLP-1s and argues the real share is likely higher, and wants use discussed openly.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
Cleveland Clinic notes there's little research and no official guidance on low-dose semaglutide, while trials show far smaller weight loss than standard dosing.
Johns Hopkins researchers report in Annals of Internal Medicine that the pill brought in new patients instead of pulling users away from injectable semaglutide.
Loading…